NPI: 1235640467 · KNOXVILLE, TN 37932 · Primary Care Clinic/Center · NPI assigned 10/16/2017
Authorized official ROSENDAHL, ANDREW controls 20+ related entities in our dataset. Read more
| Authorized Official | ROSENDAHL, ANDREW (CHIEF FINANCIAL OFFICER) |
| Parent Organization | EAST TENNESSEE CHILDREN'S HOSPITAL PRIMARY CARE CENTER, INC. |
| NPI Enumeration Date | 10/16/2017 |
Other providers sharing the same authorized official: ROSENDAHL, ANDREW
| Year | Claims | Total Paid |
|---|---|---|
| 2020 | 30 | $2K |
| 2021 | 422 | $22K |
| 2022 | 980 | $61K |
| 2023 | 1,828 | $104K |
| 2024 | 1,213 | $68K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 2,516 | 2,104 | $193K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 681 | 643 | $30K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 133 | 127 | $15K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 67 | 63 | $7K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 270 | 245 | $4K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 74 | 70 | $3K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 14 | 13 | $2K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 31 | 26 | $1K |
| 92551 | 43 | 41 | $554.99 | |
| 99177 | 52 | 49 | $242.44 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 12 | 12 | $220.00 |
| 90686 | 105 | 101 | $219.86 | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 17 | 13 | $170.17 |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 48 | 46 | $0.00 |
| 90670 | 12 | 12 | $0.00 | |
| 3008F | 398 | 373 | $0.00 |